{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12767851",
  "DateCompleted": {
    "Year": "2003",
    "Month": "09",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0195-6701",
      "JournalIssue": {
        "Volume": "54",
        "Issue": "1",
        "PubDate": {
          "Year": "2003",
          "Month": "May"
        }
      },
      "Title": "The Journal of hospital infection",
      "ISOAbbreviation": "J Hosp Infect"
    },
    "ArticleTitle": "Evidence to support the existence of subgroups within the UK epidemic Clostridium difficile strain (PCR ribotype 1).",
    "Pagination": {
      "StartPage": "74",
      "EndPage": "77",
      "MedlinePgn": "74-7"
    },
    "Abstract": {
      "AbstractText": [
        "We used three different DNA fingerprinting techniques and clindamycin susceptibility testing to confirm that Clostridium difficile PCR ribotype I isolates can be divided into two subclones. This observation may permit a better understanding of the epidemiology and pathogenicity of C. difficile infection."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, The University of Leeds and Leeds General Infirmary, Old Medical School, Leeds LS2 9JT, UK."
          }
        ],
        "LastName": "Fawley",
        "ForeName": "W N",
        "Initials": "WN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Freeman",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wilcox",
        "ForeName": "M H",
        "Initials": "MH"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Hosp Infect",
    "NlmUniqueID": "8007166",
    "ISSNLinking": "0195-6701"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "3U02EL437C",
      "NameOfSubstance": "Clindamycin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Clindamycin"
    },
    {
      "QualifierName": [
        "classification",
        "drug effects",
        "genetics",
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Clostridioides difficile"
    },
    {
      "QualifierName": [
        "epidemiology",
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Clostridium Infections"
    },
    {
      "QualifierName": [
        "epidemiology",
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "DNA Fingerprinting"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Outbreaks"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "England"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polymerase Chain Reaction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ribotyping"
    }
  ]
}